A detailed history of Manchester Capital Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Manchester Capital Management LLC holds 2 shares of NTRA stock, worth $251. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 4 50.0%
Holding current value
$251
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$85.28 - $112.6 $170 - $225
-2 Reduced 50.0%
2 $0
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $188 - $220
4 New
4 $0

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.